Type B Insulin Resistance Complicated with Systemic Lupus Erythematosus
スポンサーリンク
概要
- 論文の詳細を見る
Type B insulin resistance is characterized by the appearance of autoantibodies to the insulin receptor. We present a 59-year-old Japanese man with type B insulin resistance complicated with systemic lupus erythematosus (SLE). A high titer of anti-insulin receptor autoantibodies was revealed when SLE was defined as active disease. Intravenous boluses of cyclophosphamide (IVCY) with oral prednisolone and cyclosporin A induced remission of SLE, and a subsequent disappearance of anti-insulin receptor autoantibodies, followed by a recovery of glucose intolerance. This is a rare and important case report showing a clear correlation between anti-insulin receptor autoantibodies of type B insulin resistance and SLE disease activity.
- The Japanese Society of Internal Medicineの論文
著者
-
ORIGUCHI Tomoki
Nagasaki University School of Health Sciences
-
Iwamoto Naoki
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
Kawashiri Shin-ya
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
ARAMAKI Toshiyuki
Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomed
-
Nakamura Hideki
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
Kawakami Atsushi
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
Eguchi Katsumi
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
Fujikawa Keita
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
Tamai Mami
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
Ida Hiroaki
Unit Of Translational Medicine Department Of Immunology And Rheumatology Graduate School Of Biomedic
-
IWAMOTO Naoki
Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University
-
Origuchi Tomoki
Nagasaki University of Health Science, Nagasaki University
-
Fujikawa Keita
Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University
-
Aramaki Toshiyuki
Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University
-
TAMAI Mami
Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University
-
Kawashiri Shin-ya
Unit of Translational Medicine, Department of Immunology and Rheumatology, Graduate School of Biomedical Sciences, Nagasaki University
関連論文
- Prediction of DAS28-ESR remission at 6 months by baseline variables in patients with rheumatoid arthritis treated with etanercept in Japanese population
- Membraneous Glomerulonephritis and Non-Hodgkin's Lymphoma in a Patient with Primary Sjﾃｶgren's Syndrome
- Autoimmune hepatitis in a patient with systemic lupus erythematosus : a case report
- A case of Sjogren's syndrome presenting as hypokalemic myopathy due to distal renal tubular acidosis
- A significantly impaired natural killer cell activity due to a low activity on a per-cell basis in rheumatoid arthritis
- Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis
- Characterization of anticytoplasmic antibodies in patients with systemic autoimmune diseases
- A case of amyloidosis secondary to rheumatoid arthritis complicated with Graves' ophthalmopathy
- Atypical mycobacteriosis in two patients with rheumatoid arthritis
- Successful Combined Therapy of Cyclophosphamide and Cyclosporine for Acute Exacerbated Interstitial Pneumonia Associated with Dermatomyositis
- Deep vein thrombosis and pulmonary thromboembolism in a patient with eosinophilia and obesity
- A case of cold agglutinin disease in the course of treatment for polymyalgia rheumatica
- Cutaneous vasculitis induced by TNF inhibitors : a report of three cases
- Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics
- Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables
- Successful treatment of chronic lupus myocarditis with prednisolone and mizoribine
- Long-term efficacy of intravenously administered immunoglobulin in a case of polymyositis with limited application of steroid therapy.
- Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1^*shared epitope-negative rheuma
- Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8mg/week in patients with rheumatoid arthritis
- In rheumatoid arthritis patients treated with tocilizumab, the rate of clinical disease activity index (CDAI) remission at 24 weeks is superior in those with higher titers of IgM-rheumatoid factor at baseline
- Disease activity score 28 may overestimate the remission induction of rheumatoid arthritis patients treated with tocilizumab : comparison with the remission by the clinical disease activity index
- Successful Treatment of a Patient with Primary Sjögren's Syndrome Complicated with Pericarditis during Pregnancy
- Successful treatment of a patient with IgG4-related disease with a paravertebral mass lesion
- Efficacy of adalimumab for a refractory case of relapsing polychondritis with reduction of pro-inflammatory cytokines
- Increased incidence of pre-diabetes mellitus at a department of rheumatology : a retrospective study
- Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows and excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors
- A case of Sjogren syndrome with pulmonary amyloidosis complicating microscopic polyangiitis
- A patient with systemic lupus erythematosus who developed massive small intestinal hemorrhaging during treatment for chronic lupus peritonitis
- Treatment discontinuation in patients with very early rheumatoid arthritis in sustained simplified disease activity index remission after synthetic disease-modifying anti-rheumatic drug administration
- A case of Sjogren's syndrome presenting as trigeminal nerve palsy
- Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis : comparison of the accuracy of plain MRI-based findings and gadolinium-diethylenetriamine pentaacetic acid-enhanc
- Thyroid papillary carcinoma with solid sclerosing change in IgG4-related sclerosing disease
- Type B Insulin Resistance Complicated with Systemic Lupus Erythematosus
- Examination of IgM Rheumatoid Factor (IgM-RF) and Anti-cyclic Citrullinated Peptide Antibody (Anti-CCP Ab) in Japanese Patients with Palindromic Rheumatism
- Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate
- Sweet's Syndrome Complicated by Kikuchi's Disease and Hemophagocytic Syndrome which Presented with Retinoic Acid-inducible Gene-I in both the Skin Epidermal Basal Layer and the Cervical Lymph Nodes
- A case of IgG4-related pulmonary disease with rapid improvement
- Development of Adult T-cell Leukemia in a Patient with Rheumatoid Arthritis Treated with Tocilizumab
- Takayasu arteritis developing during treatment of ulcerative colitis with infliximab
- Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease : a report of two cases
- Significant improvement in MRI-proven bone edema is associated with protection from structural damage in very early RA patients managed using the tight control approach